
Today's focus
1. San'an Optoelectronics: All 26.30% of the shares held by the controlling shareholders and indirect controlling shareholders have been frozen, and a total of 166.81% of the total share capital is pending freezing
San'an Optoelectronics (600703.SH) announced that 386.949 million shares held by Fujian Sanan Group, the indirect controlling shareholder, were suspended by the Shanghai Financial Court, accounting for 21.22% of its shares and 0.78% of the company's total share capital. This was triggered by a dispute between Xinxin Financial Leasing Group and San'an Group and Nissan PV financial leasing contracts. As of November 18, the controlling shareholders, Xiamen Sanan Electronics and Sanan Group, held a total of 1,312 billion shares, accounting for 26.30% of the total share capital, and have all been judicially frozen. After the freeze, the two shareholders had a total of 8.322 billion shares pending freezing, accounting for 634.17% of the number of shares they hold and 166.81% of the company's total share capital. According to the company, the controlling shareholder and the company maintain independence in terms of assets, business, finance, etc., and there are no situations that infringe on the interests of listed companies, such as non-operating capital occupation or illegal guarantees. The above freeze will not have a significant impact on control rights or corporate governance; if not properly resolved in the future, there is a risk that it will affect the stability of control rights.
2. Changxin Technology: The repurchase amount was adjusted to 2.5 billion yuan to 5 billion yuan, of which 1.5 billion yuan to 3 billion yuan was used to maintain the company's value and cancel
Changxin Technology (688825.SH) announced that the board of directors reviewed and approved the adjustment of the repurchase plan. The total repurchase capital is not less than 2.5 billion yuan, no more than 5 billion yuan, and the maximum price is 63.78 yuan/share. The funding source is own or self-raised. Of these, the amounts used for equity incentives or employee stock ownership plans, cancellation, and reduction of registered capital are each of 500 million yuan to 1 billion yuan, and those used to protect the company's value and shareholders' rights are 1.5 billion yuan to 3 billion yuan. This portion of the shares will be cancelled after the repurchase is completed. The implementation period for the incentive and cancellation portion is within 12 months after review and approval by the shareholders' meeting and requires 6 months of the company's listing, and within 3 months for the maintenance value portion. The plan still needs to be reviewed by the shareholders' meeting on December 9. As of November 6, the closing price was 40.41 yuan/share, with a cumulative decline of 20% for 20 consecutive trading days, in line with the “necessary to protect the company's value and shareholders' rights” situation.
3. Haiguang Information: First repurchase of 1.376,700 shares at a cost of 235 million yuan
Haiguang Information (688041.SH) announced that the company repurchased 1.376,700 shares for the first time through centralized bidding, accounting for 0.06% of the total share capital. The transaction price was 162.69 yuan to 174.99 yuan/share, and the payment capital was 235 million yuan. The total repurchase plan is 500 million yuan to 800 million yuan, and the maximum price is 318.52 yuan/share. The capital is owned or self-funded. The company has obtained a special repurchase loan commitment of no more than 720 million yuan from China CITIC Bank Beijing Branch. According to the company, the current supply chain system is stable, market demand for CPU and DCU products continues to increase, and next-generation product development is progressing steadily according to the established route.
4. Suiyuan Technology: The cumulative deviation value of the three-day decline exceeded 30%, saying that there were plenty of orders in hand and tradable stocks only accounted for 4.16% of the total share capital
Suiyuan Technology (688801.SH) announced that the cumulative deviation value of the closing price drop of the company's stock for three consecutive trading days from November 17 to 19 reached more than 30%, which is an abnormal fluctuation in stock trading. After self-inspection and written consultation with the actual controller, the company and the actual controller confirmed that there was no material information that should have been disclosed but not disclosed, including matters such as mergers and acquisitions, share issuance, and asset injections. The company said it has noticed that related industry news has attracted a lot of attention recently. Currently, there are plenty of orders in hand, and it is cooperating with many domestic semiconductor industry partners to create cloud-based AI chip products based on the domestic supply chain. At the same time, the company indicated that currently there is an unlimited sale of 17.9.03 million tradable shares, accounting for only 4.1595% of the total share capital. The number of tradable shares is small, and the short-term fluctuation in stock prices is large.
5. Crystal integration: Signed capital increase agreements with Hefei Construction Investment and others, and the three parties pledged additional registered capital for a total of 9.1 billion yuan
Crystal Integration (688249.SH) announced that the company, Hefei Construction Investment and Hefei Qinhe signed a capital increase agreement with the target company on November 19, and the three parties pledged a total of 9.1 billion yuan in cash to increase the registered capital of the target company. The agreement was established after being signed and sealed by statutory representatives or authorized representatives of various laws, and takes effect after the company's shareholders' meeting reviews and approves the capital increase. Independent shareholders' approval is still required; a circular containing details of the capital increase agreement, a letter from the independent board committee, and the opinions of independent financial advisors is expected to be published on or before December 31.
6. Kefu Healthcare: Acquired 60% of Kang Juren's shares for 99.48 million yuan, and the target will be included in the consolidated statement
Kefu Medical (301087.SZ) announced that the company signed an equity transfer agreement with Guo Bensheng, Guo Benli and Anhui Oxygen Genie Enterprise Management Consulting to acquire 60% of Hefei Kangjuren Medical Device Technology's shares with its own capital of 99.48 million yuan. After the transaction was completed, Kangjuren became a holding subsidiary and included in the scope of the consolidated statement. The transaction has been reviewed and approved by the board of directors. It does not require submission to the shareholders' meeting, does not constitute a related transaction, and does not constitute a major asset restructuring.
7. Yuantong Express: Revenue from express delivery products in October was 6.512 billion yuan, up 4.76% year on year
Yuantong Express (600233.SH) announced that in October 2026, express delivery product revenue was 6.512 billion yuan, up 4.76% year on year, business completed volume of 3,062 billion tickets, up 9.77% year on year, and single ticket revenue for express delivery products was 2.13 yuan, down 4.56% year on year. The above data has not been audited.
Buyback & increase or decrease holdings
1. Ganfeng Lithium: Plans to repurchase 200 million yuan to 400 million yuan, with a maximum price of 57.47 yuan/share
Ganfeng Lithium (002460.SZ) announced that it is expected to repurchase 0.17% to 0.33% of the shares to maintain the company's value.
2. Baiwei Storage: Proposed repurchase of 200 million yuan to 250 million yuan, all of which will be used to cancel capital reduction
Baiwei Storage (688525.SH) announced that the upper price limit is 269.47 yuan/share, and the plan has been reviewed and approved by the shareholders' meeting.
3. Century Huatong: First repurchase of 3.6031 million shares at a cost of 388.17,700 yuan
Century Huatong (002602.SZ) announced that the transaction price was 10.73 yuan to 10.82 yuan/share, and the total plan was 300 million yuan to 600 million yuan.
4. Jinke shares: Proposed repurchase of 150 million yuan to 300 million yuan, with a maximum price of 1.5 yuan/share
Jinke Co., Ltd. (000656.SZ) announced that in order to maintain the company's value, it closed down 21.62% in 20 trading days.
Sign a big order
1. CSPC Innovation: Received Corbus's $15 million authorized milestone
CSPC Innovation (300765.SZ) announced that the CRB-701 project has collected a cumulative total of 32.5 million US dollars, which will boost performance.
2. Energy Saving Guozhen: The consortium won the bid for 396 million yuan ten water plant projects
Energy Saving Guozhen (300388.SZ) announced that the company is responsible for 30% of the project volume and has not yet signed a formal contract.
others
1. Hengrui Pharmaceutical: New indications for Class 1 innovative drugs have been approved, with a total R&D investment of 260 million yuan
Hengrui Pharmaceutical (600276.SH) announced that prorolapitamparonosetron has added additional MEC vomiting prevention indications.
2. National Shield Quantum: Controlling shareholders and others promise not to reduce their holdings until the end of 2027
National Shield Quantum (688027.SH) announced that the pledging entities held a total of 34.05% of the shares, including 21.86% of China Telecom Quantum Group.